POCKIT™ Central C. difficile is intended for use with POCKIT™ Central system. The assay, targeting the toxin B (tcdB) gene, is an in vitro diagnostic1 molecular assay for qualitative detection of toxigenic C. difficile in liquid or soft stool from patients suspected of C. difficile infection. The assay is intended to aid in the diagnosis of C. difficile infection.

1 Not FDA cleared or approved yet.

Features

  • ■ Cost effective
       - Minimal hands-on time
       - Walk-away molecular testing protocols
       - Better workflow management
       - STAT, increasing productivity
  • ■ User friendly
       - Minimal dexterity required
       - Preloaded ready-to-use cartridges
       - Universal pre-programmed protocols
       - Direct display of test results
  • ■ Reliable
       - Proven iiPCR technology
       - Accurate results with internal control

Sample-in-answer-out in a Few Steps

Technical Information

Overall agreement………………………………………… 94.8%
Positive agreement ………………………………………  92.6%
Negative agreement ……………………………………… 96.0%

*Compared to a C. difficile real-time PCR assay

Ordering Information

Reagent

Product Name
Cat.No.
Specifications
POCKIT™ Central C. difficileapcri-110

24 tests/set including:

- Stool Pretreatment Set  

- Extraction Cartridges  

- C. difficile Reagent Cartridges

- C. difficile Internal Control


Instrument

Product Name
Cat.No.
Specifications
POCKIT™ Central Nucleic Acid Analyzerapcc-1i

Throughput: 1-8 samples